Results 131 to 140 of about 21,265 (190)

In Silico and In Vitro Profiling of Honokiol and Paclitaxel-Loaded PBM Nanoparticles for Targeted Breast Cancer Delivery. [PDF]

Pharmaceuticals (Basel)
Kinnel B, Srivastava AK, Singh SK, Singh R.   +3 more
europepmc   +1 more source

Studies on a Sulfoxide-Bridged Tn Antigen Mimetic: Interaction with Macrophage Galactose Lectin and Inhibition of Sialyltransferase ST6GALNAC1. [PDF]

ACS Omega
Sodini A, Casali E, Travecedo MA, Marcelo F, Chiodo F, Rambaldi F, van Vliet SJ, Dall'Olio F, Nativi C.   +8 more
europepmc   +1 more source

<i>In situ</i> self-assembling rebamipide-based eye drops to promote secretion of mucin for treatment of dry eye. [PDF]

Mater Today Bio
Lv G, Lei L, Wang J, Yang Y, Zou Y, Xie S, Wang L, Liu X, Li C, Wang H, Li X, Wang J.   +11 more
europepmc   +1 more source

Immunoglobulin GM (γ marker) allotypes expressed on IgG1 as potential genetic markers of response to immune checkpoint blockade therapy. [PDF]

J Immunother Cancer
Pandey JP.
europepmc   +1 more source

Clinically aggressive early-onset pancreatic ductal adenocarcinoma with KRAS wild-type status: A case report. [PDF]

Biomed Rep
Avendaño ME, San Martin Abello C, Gómez-Valenzuela F, Silva I, Retamal IN, García-Bloj B, De Mayo Glaser T, Muñoz-Medel M, Gómez A, Sánchez C, Pinto F, Aravena P, Sabioncello AC, Garrido Villanueva M, Sigler Chávez F, Corvalán I, Barrios H, Sáez MA, Erpel JM, Manque PA, Rios JA, Godoy JA, Garrido M.   +22 more
europepmc   +1 more source

Therapeutic Efficacy of Rapamycin in an Experimental Mouse Model of Corneal Alkali Burn. [PDF]

Int J Mol Sci
Bhujel B, Lee H, Chung HS, Kim JY.
europepmc   +1 more source

Correction to "The Activation of cGAS-STING Pathway Causes Abnormal Uterine Receptivity in Aged Mice". [PDF]

Aging Cell
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Cancer Immunology, Immunotherapy, 2000
Analyses of MUC1-specific cytotoxic T cell precursor (CTLp) frequencies were performed in mice immunized with three different MUC1 vaccine immunotherapeutic agents. Mice were immunized with either a fusion protein comprising MUC1 and glutathione S-transferase (MUC1-GST), MUC1-GST fusion protein coupled to mannan (MFP) or with a recombinant vaccinia ...
Vasso Apostolopoulos, Jean-Marc Balloul, P X Xing   +2 more
exaly   +3 more sources

Muc1 Immunotherapy

Immunotherapy, 2010
The overexpression and aberrant glycosylation of MUC1 is associated with a wide variety of cancers, making it an ideal target for immunotherapeutic strategies. This review highlights the main avenues of research in this field, focusing on adenocarcinomas, from the preclinical to clinical; the problems and possible solutions associated with each ...
Beatson, Richard, Burchell, Joy, Taylor-Papadimitriou, Joyce   +2 more
openaire   +3 more sources

MUC1 expression in plasmacytoma

Leukemia Research, 2001
Plasmacytoma (Pm) is a plasma cell (PC) neoplasia consisting of PCs and some of them show progression to multiple myeloma. But there is no clear indicators predicting this progression. In this study, MUC1 expression was evaluated in Pm cases to determine the predictive value and was compared with histopathologic grade which is known to be a prognostic ...
Paydaş S., Şahin B., Gönlüşen G., Hazar B., Zorludemir S.   +4 more
openaire   +3 more sources